Top Markets
Coin of the day
Sinew Pharma Inc. Sinew Pharma Inc.

Sinew Pharma Inc.

6634
Clasificación en acciones #20256
Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research,... Sinew Pharma Inc. is a biopharmaceutical enterprise dedicated to the research, development, and commercialization of new therapeutics. Its core mission revolves around pioneering innovative solutions for hepatotoxicity-free acetaminophen and addressing various fatty liver conditions. The company's robust pipeline features SNP-610, a drug candidate currently advancing through Phase II clinical trials in Taiwan for the treatment of non-alcoholic steatohepatitis (NASH). Another early-stage compound, SNP-630, is also in preclinical development, targeting NASH. Beyond liver disease, Sinew Pharma is progressing SNP-810 for its analgesic and antipyretic properties. Furthermore, the firm is developing SNP-830 and SNP-840, positioned as liver-safe pain medications specifically for the United States market. Established in 2014, Sinew Pharma Inc. maintains its headquarters in Taipei City, Taiwan.
Precio por acción
$1.90
Capitalización bursátil
$135.79M
Cambio (1 día)
-0.50%
Cambio (1 año)
20.89%
País
TW
Comercio Sinew Pharma Inc. (6634)

Categoría

Historial de desdoblamientos de acciones de Sinew Pharma Inc. (6634)
La acción Sinew Pharma Inc. (símbolo: 6634) tuvo un total de 0 desdoblamientos.
El desdoblamiento más reciente ocurrió el Aug 25, 2026.
Una acción 6634 comprada antes de Aug 25, 2026 equivaldría hoy a 0 acciones 6634.
Lista de desdoblamientos de acciones
Año Desdoblamiento Multiplicador Multiplicador acumulado
Not enough data for the provided dates.
Desdoblamientos de acciones de empresas similares o competidoras
Empresa Número de desdoblamientos de acciones Multiplicador acumulado País
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH